SEC Form D private-offering filing
Prelude Corp
A new SEC Form D private-offering notice from Laguna Hills, CA, a $7,500,000 filer-stated offering target in Biotech. The source filing is one click away.
Molecular diagnostics company behind DCISionRT, a genomic test that predicts radiation therapy benefit for patients with ductal carcinoma in situ (DCIS) breast cancer.
Filed 2025-11-06Filed to raise $7,500,000First money in 2025-10-30Raised so far $5,000,000HQ (as filed) Laguna Hills, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified preludedx.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.